Fol. Biol. 2022, 68, 16-24
https://doi.org/10.14712/fb2022068010016
C-Phycocyanin Suppresses Cell Proliferation and Promotes Apoptosis by Regulating the AMPK Pathway in NCL-H292 Non-Small Cell Lung Cancer Cells
References
1. 2012) Characterization and bioactivity of phycocyanin isolated from Spirulina maxima grown under salt stress. Food Funct. 3, 381-388.
< , H. H., El-Baroty, G. S. (https://doi.org/10.1039/c2fo10194g>
2. 2020) LncRNA NBR2 suppresses migration and invasion of colorectal cancer cells by downregulating miRNA-21. Hum. Cell 33, 98-103.
< , J., Xu, J., Zhao, J., Zhang, R. (https://doi.org/10.1007/s13577-019-00265-1>
3. 2008) C-Phycocyanin inhibits cell proliferation and may induce apoptosis in human HepG2 cells. Egypt. J. Immunol. 15, 161-167.
, O. M., Hafez, R. A., El-Ayouty, Y. M., Mahrous, K. F., Bareedy, M. H., Salama, A. M. (
4. 2013) Antiproliferative activity of Cyanophora paradoxa pigments in melanoma, breast and lung cancer cells. Mar. Drugs 11, 4390-4406.
< , P. H., Gagez, A. L., Berard, J. B., Juin, C., Bridiau, N., Kaas, R., Thiery, V., Cadoret, J. P., Picot, L. (https://doi.org/10.3390/md11114390>
5. 2016) Study of the effects of betaine and/or C-phycocyanin on the growth of lung cancer A549 cells in vitro and in vivo. J. Oncol. 2016, 8162952.
< , R., Dupuis, C., Pichon, C., Berthon, J. Y., Filaire, M., Pigeon, L., Filaire, E. (https://doi.org/10.1155/2016/8162952>
6. 2020) Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy. Cancer Immunol. Immunother. 70, 1177-1188.
< , E. M., Diaz-Pena, R., Garcia-Gonzalez, J., Leon-Mateos, L., Mondelo-Macia, P., Pena-Chilet, M., Lopez-Lopez, R. (https://doi.org/10.1007/s00262-020-02752-z>
7. 2012) Immunomodulatory properties of the protein fraction from Phorphyra columbina. J. Agric. Food Chem. 60, 8146-8154.
< , R. E., Lopez-Posadas, R., Drago, S. R., de Medina, F. S., Martinez-Augustin, O. (https://doi.org/10.1021/jf300928j>
8. 2018) Effect of liposome-mediated HSP27 transfection on collagen synthesis in alveolar type II epithelial cells. Mol. Med. Rep. 17, 7319-7324.
, H., Gao, X., Peng, H., Wang, J., Hou, X., Xu, H., Yang, F. (
9. 2001) Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells. Folia Biol. (Praha) 47, 120-127.
, S. D., Matouskova, E., Forejt, J. (
10. 2019) LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC. Eur. Rev. Med. Pharmacol. Sci. 23, 7950-7958.
, Y. P., Li, Y., Li, H. J., Zhao, B. (
11. Hamouri, S., Alrabadi, N., Syaj, S., Abushukair, H., Ababneh, O., Al-Kraimeen, L., Al-Sous, M., Hecker, E. (2022) Atrial resection for T4 non-small cell lung cancer with left atrium involvement: a systematic review and meta-analysis of survival. Surg. Today, online ahead of print.
<https://doi.org/10.1007/s00595-021-02446-8>
12. 2019) C-Phycocyanin suppresses the in vitro proliferation and migration of non-small-cell lung cancer cells through reduction of RIPK1/NF-κB activity. Mar. Drugs 17, 362.
< , S., Li, S., Wang, J., Zhao, L., Yan, Y., Wu, T., Zhang, J., Wang, C. (https://doi.org/10.3390/md17060362>
13. 2017) A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. Biomedicine (Taipei) 7, 23.
< , C. Y., Ju, D. T., Chang, C. F., Muralidhar Reddy, P., Velmurugan, B. K. (https://doi.org/10.1051/bmdcn/2017070423>
14. 2012) AMPK and mTOR in cellular energy homeostasis and drug targets. Annu. Rev. Pharmacol. Toxicol. 52, 381-400.
< , K., Kim, J., Guan, K. L. (https://doi.org/10.1146/annurev-pharmtox-010611-134537>
15. 2020) C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells. Cancer Cell Int. 20, 292.
< , H., Liu, G., Han, J., Zhu, F., Dong, X., Li, B. (https://doi.org/10.1186/s12935-020-01384-8>
16. 2018) C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells. Cancer Cell Int. 18, 12.
< , L., Wang, Y., Liu, G., Liu, H., Zhu, F., Ji, H., Li, B. (https://doi.org/10.1186/s12935-018-0511-5>
17. 2020) Molecular mechanism of C-phycocyanin induced apoptosis in LNCaP cells. Bioorg. Med. Chem. 28, 115272.
< , P., Dhandayuthapani, S., Venkatesan, T., Gantor, M., Rathinavelu, A. (https://doi.org/10.1016/j.bmc.2019.115272>
18. 2021) Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway. Cancer Cell Int. 21, 706.
< , H. B., Chen, J. K., Su, Z. X., Jin, Q. L., Deng, L. W., Huang, G., Shen, J. N. (https://doi.org/10.1186/s12935-021-02411-y>
19. 2016) LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat. Cell Biol. 18, 431-442.
< , X., Xiao, Z. D., Han, L., Zhang, J., Lee, S. W., Wang, W., Lee, H., Zhuang, L., Chen, J., Lin, H. K., Wang, J., Liang, H., Gan, B. (https://doi.org/10.1038/ncb3328>
20. 2019) KIAA1211 plays an oncogenic role in human non-small cell lung cancer. J. Cancer 10, 6747-6753.
< , Z., Cao, H., Shi, Y., Yang, R. (https://doi.org/10.7150/jca.35951>
21. 2017) Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol. Cancer 16, 118.
< , W., Zhang, H., Niu, Y., Wu, Y., Sun, W., Li, H., Kong, J., Ding, K., Shen, H. M., Wu, H., Xia, D., Wu, Y. (https://doi.org/10.1186/s12943-017-0685-9>
22. 2019) Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69, 363-385.
< , K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., Siegel, R. L. (https://doi.org/10.3322/caac.21565>
23. 2015) C-Phycocyanin protects against acute tributyltin chloride neurotoxicity by modulating glial cell activity along with its anti-oxidant and anti-inflammatory property: a comparative efficacy evaluation with N-acetyl cysteine in adult rat brain. Chem. Biol. Interact. 238, 138-150.
< , S., Siddiqui, W. A., Khandelwal, S. (https://doi.org/10.1016/j.cbi.2015.06.016>
24. 2021) Anticancer drug resistance: an update and perspective. Drug Resist. Updat. 59, 100796.
< , R., Tsai, C. J., Jang, H. (https://doi.org/10.1016/j.drup.2021.100796>
25. 2020) The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential. Biochim. Biophys. Acta Rev. Cancer 1874, 188423.
< , G., Kirtonia, A., Sethi, G., Pandey, A. K., Garg, M. (https://doi.org/10.1016/j.bbcan.2020.188423>
26. 2016) Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC. Oncotarget 7, 60169-60180.
< , J., Chen, L., Quan, T., Li, L., Quan, C., Piao, Y., Jin, T., Lin, Z. (https://doi.org/10.18632/oncotarget.11109>
27. 2013) An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat. Bioinforma. Biomath. 3, 71-85.
, X., Huang, X., Zhou, Z., Lin, X. (
28. 2018) C-Phycocyanin inhibits hepatic gluconeogenesis and increases glycogen synthesis via activating Akt and AMPK in insulin resistance hepatocytes. Food Funct. 9, 2829-2839.
< , Z., Xie, Z., Cao, D., Gong, M., Yang, L., Zhou, Z., Ou, Y. (https://doi.org/10.1039/C8FO00257F>
29. Rio, D. C., Ares, M. Jr., Hannon, G. J., Nilsen, T. W. (2010) Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb. Protoc. 2010, pdb.prot5439.
30. 2014) Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer. J. Thorac. Oncol. 9, 1294-1304.
< , L. H., Görlich, D., Spieker, T., Rohde, C., Schuler, M., Mohr, M., Humberg, J., Sauer, T., Thoenissen, N. H., Huge, A., Voss, R., Marra, A., Faldum, A., Müller-Tidow, C., Berdel, W. E., Wiewrodt, R. (https://doi.org/10.1097/JTO.0000000000000243>
31. 2010) Association of antidiabetic therapies to glycemic control and to body weight in type 2 diabetes: a German multicenter analysis on 9294 patients. Exp. Clin. Endocrinol. Diabetes 118, 490-495.
< , M., Kern, W., Zimmermann, A., Busch, P., Kerner, W., Voll, A., Wagner, C., Kann, P. H., Dapp, A., Holl, R. W.; DPV initiative; German BMBF Competence Network Diabetes mellitus (https://doi.org/10.1055/s-0030-1249024>
32. 2017) Purification and antioxidant activity of phycocyanin from Synechococcus sp. R42DM isolated from industrially polluted site. Bioresour. Technol. 245, 325-331.
< , R. R., Patel, S., Bhastana, B., Jakharia, K., Chaubey, M. G., Singh, N. K., Madamwar, D. (https://doi.org/10.1016/j.biortech.2017.08.129>
33. 2013) lincRNAs: genomics, evolution, and mechanisms. Cell 154, 26-46.
< , I., Bartel, D. P. (https://doi.org/10.1016/j.cell.2013.06.020>
34. 2007) The recombinant beta subunit of C-phycocyanin inhibits cell proliferation and induces apoptosis. Cancer Lett. 247, 150-158.
< , H., Liu, Y., Gao, X., Carter, C. L., Liu, Z. R. (https://doi.org/10.1016/j.canlet.2006.04.002>
35. 2018) mTOR signaling-related microRNAs and cancer involvement. J. Cancer 9, 667-673.
< , P., Liu, X. M., Ding, L., Zhang, X. J., Ma, Z. L. (https://doi.org/10.7150/jca.22119>
36. 1997) Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum. Mol. Genet. 6, 1057-1062.
< , C. F., Brown, M. A., Nicolai, H., Chambers, J. A., Griffiths, B. L., Solomon, E. (https://doi.org/10.1093/hmg/6.7.1057>
37. 2020) m6 A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer. J. Cell. Physiol. 236, 2649-2658.
< , L., Li, J., Lin, Y., Liu, D., Yang, Q., Jian, J., Peng, J. (https://doi.org/10.1002/jcp.30023>
38. 2020) LncRNA NBR2 inhibits the malignancy of thyroid cancer, associated with enhancing the AMPK signaling. Front. Oncol. 10, 956.
< , W., Zheng, Z., Yi, P., Wang, S., Zhang, N., Ming, J., Tan, J., Guo, H. (https://doi.org/10.3389/fonc.2020.00956>
39. 2021) Distinct mitochondria-mediated T-cell apoptosis responses in children and adults with coronavirus disease 2019. J. Infect. Dis. 224, 1333-1344.
< , Y., Kuang, L., Li, L., Wu, Y., Zhong, B., Huang, X. (https://doi.org/10.1093/infdis/jiab400>
40. 2022) SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK. Cell Death Diff. 29, 1395-1408.
< , Y., Wu, Y., Meng, X., Wang, Z., Younis, M., Liu, Y., Wang, P., Huang, X. (https://doi.org/10.1038/s41418-022-00928-x>
41. 2017) Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells. Int. J. Nanomedicine 12, 6537-6558.
< , Y. G., Gurunathan, S. (https://doi.org/10.2147/IJN.S125281>
42. 2020a) Long noncoding RNA PANDAR inhibits the development of lung cancer by regulating autophagy and apoptosis pathways. J. Cancer 11, 4783-4790.
< , L., Wang, Y., Xia, S., Yang, L., Wu, D., Zhou, Y., Lu, J. (https://doi.org/10.7150/jca.45291>
43. 2020b) Mechanisms of long non-coding RNAs in cancers and their dynamic regulations. Cancers (Basel) 12, 1245.
< , X. Z., Liu, H., Chen, S. R. (https://doi.org/10.3390/cancers12051245>